- Home
- SHFS vs COCP Comparison
SHFS vs COCP Comparison
Compare SHFS & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- COCP
- Stock Information
- Founded
- SHFS 2015
- COCP N/A
- Country
- SHFS United States
- COCP United States
- Employees
- SHFS N/A
- COCP N/A
- Industry
- SHFS Finance: Consumer Services
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- SHFS Finance
- COCP Health Care
- Exchange
- SHFS Nasdaq
- COCP Nasdaq
- Market Cap
- SHFS 20.8M
- COCP 20.1M
- IPO Year
- SHFS N/A
- COCP N/A
- Fundamental
- Price
- SHFS $0.37
- COCP $1.95
- Analyst Decision
- SHFS
- COCP Strong Buy
- Analyst Count
- SHFS 0
- COCP 1
- Target Price
- SHFS N/A
- COCP $7.00
- AVG Volume (30 Days)
- SHFS 118.1K
- COCP 31.5K
- Earning Date
- SHFS 03-31-2025
- COCP 03-27-2025
- Dividend Yield
- SHFS N/A
- COCP N/A
- EPS Growth
- SHFS N/A
- COCP N/A
- EPS
- SHFS 0.10
- COCP N/A
- Revenue
- SHFS $15,658,629.00
- COCP N/A
- Revenue This Year
- SHFS N/A
- COCP N/A
- Revenue Next Year
- SHFS N/A
- COCP N/A
- P/E Ratio
- SHFS $3.65
- COCP N/A
- Revenue Growth
- SHFS 7.78
- COCP N/A
- 52 Week Low
- SHFS $0.30
- COCP $1.35
- 52 Week High
- SHFS $1.01
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- SHFS 37.36
- COCP 47.95
- Support Level
- SHFS $0.38
- COCP $1.75
- Resistance Level
- SHFS $0.44
- COCP $2.08
- Average True Range (ATR)
- SHFS 0.03
- COCP 0.20
- MACD
- SHFS -0.01
- COCP 0.00
- Stochastic Oscillator
- SHFS 2.73
- COCP 45.07
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).